Key Findings Policy discussion surrounding U.S. prescription drug prices focuses on whether prices in the United States are too high or appropriate relative to the benefits that they offer to patients.
International Drug Pricing
Displaying 1 - 4 of 4. 10 per page. Page 1.Advanced Search
International Prescription Drug Price Comparisons: Current Empirical Estimates and Comparisons with Previous Studies
July 1, 2022
Assessing Relationships between Drug Shortages in the United States and Other Countries
October 13, 2021
Drug shortages are a persistent public health problem in the United States and in other countries. Shortages can have important implications for the health care systems and pharmacies that purchase, store, and dispense drugs and for the patients who rely on the availability of drugs to treat and prevent disease.
Medicare FFS Part B and International Drug Prices: A Comparison of the Top 50 Drugs
November 19, 2020
The September 13, 2020 Executive Order on Lowering Drug Prices by Putting America First declared, “It is the policy of the United States that the Medicare program should not pay more for costly Part B or Part D prescription drugs or biological products than the most-favored-nation price.” The Most Favored Nation (MFN) Model issued by the Centers for Medicare & Medicaid Services (CMS) on No
Comparing Insulin Prices in the U.S. to Other Countries
September 23, 2020
Insulin prices have increased dramatically over the past decade in the United States. This report presents results from international price comparisons of insulins using a price index approach.